 Home > Active Ingredient News > Drugs Articles > Dece Pharma announces that Celiniso's Phase II clinical trial application has been approved in China for the treatment of myelofibrosis

Dece Pharma announces that Celiniso's Phase II clinical trial application has been approved in China for the treatment of myelofibrosis

 Last Update: 2021-09-04
 Source: Internet
 Author: User

Tags

soap products

cancer cell growth

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On August 23, Deqi Pharmaceutical announced that the National Medical Products Administration (NMPA) approved Celiniso (XPOVIO®) to carry out a phase II clinical trial for the treatment of patients with myelofibrosis (MF) in China

The National Medical Products Administration (NMPA) approves Celiniso (XPOVIO®) to conduct a phase II clinical trial in China for the treatment of patients with myelofibrosis (MF)

Myelofibrosis (MF) is a clonal myeloproliferative tumor, including primary myelofibrosis (PMF), post-polycythemia vera (PV) or post-essential thrombocythemia (ET) myelofibrosis

The trial is a phase II, randomized, open-ended, global multi-center clinical study, with the First Affiliated Hospital of Soochow University as the lead research center in China.

Principal Investigator Professor Wu Depei, Director of the Department of Hematology, The First Affiliated Hospital of Soochow University

Dr.

About Celiniso (XPOVIO®)

Celiniso is the first and only oral selective nuclear export inhibitor (SINE) compound of its kind.

In July 2019, the U.

Celiniso is currently the first and only oral SINE compound approved by the US FDA and the first drug that can be used to treat multiple myeloma and diffuse large B-cell lymphoma at the same time

Deqi Pharmaceuticals is carrying out a number of clinical trials in China for the treatment of multiple myeloma, diffuse large B-cell lymphoma, endometrial cancer, and peripheral T-cell and NK/T-cell lymphomas.

About Deqi Pharmaceutical

Deqi Pharmaceutical Co.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Best price Pure Tirzepatide powder 10mg vial Tirzepatide CAS 2023788-19-2 ouda

CAS No.: 2023788-19-2

Pharmacy Grade

$40.00/G FOB

Safe Delivery Freeze Dried Peptides Raw Powder Weight Loss Tirze Peptide Sema 5mg 10mg

CAS No.: 2023788-19-2

Pharmacy Grade

$120.00/UNIT FOB

RU 58841 CAS 154992-24-2 RU58841 Powder Bulk RU-58841 For Hair Growth and Anti Hair Loss

CAS No.: 154992-24-2

Pharmacy Grade

$1-1.2/KG FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.